Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community

Significance Lack of human data on influenza virus aerosol shedding fuels debate over the importance of airborne transmission. We provide overwhelming evidence that humans generate infectious aerosols and quantitative data to improve mathematical models of transmission and public health interventions. We show that sneezing is rare and not important for—and that coughing is not required for—influenza virus aerosolization. Our findings, that upper and lower airway infection are independent and that fine-particle exhaled aerosols reflect infection in the lung, opened a pathway for a deeper understanding of the human biology of influenza infection and transmission. Our observation of an association between repeated vaccination and increased viral aerosol generation demonstrated the power of our method, but needs confirmation. Little is known about the amount and infectiousness of influenza virus shed into exhaled breath. This contributes to uncertainty about the importance of airborne influenza transmission. We screened 355 symptomatic volunteers with acute respiratory illness and report 142 cases with confirmed influenza infection who provided 218 paired nasopharyngeal (NP) and 30-minute breath samples (coarse >5-µm and fine ≤5-µm fractions) on days 1–3 after symptom onset. We assessed viral RNA copy number for all samples and cultured NP swabs and fine aerosols. We recovered infectious virus from 52 (39%) of the fine aerosols and 150 (89%) of the NP swabs with valid cultures. The geometric mean RNA copy numbers were 3.8 × 104/30-minutes fine-, 1.2 × 104/30-minutes coarse-aerosol sample, and 8.2 × 108 per NP swab. Fine- and coarse-aerosol viral RNA were positively associated with body mass index and number of coughs and negatively associated with increasing days since symptom onset in adjusted models. Fine-aerosol viral RNA was also positively associated with having influenza vaccination for both the current and prior season. NP swab viral RNA was positively associated with upper respiratory symptoms and negatively associated with age but was not significantly associated with fine- or coarse-aerosol viral RNA or their predictors. Sneezing was rare, and sneezing and coughing were not necessary for infectious aerosol generation. Our observations suggest that influenza infection in the upper and lower airways are compartmentalized and independent.

[1]  Yuguo Li,et al.  Transmission of influenza A in human beings , 2007, The Lancet Infectious Diseases.

[2]  Rachael M. Jones,et al.  Relative Contributions of Four Exposure Pathways to Influenza Infection Risk , 2009, Risk analysis : an official publication of the Society for Risk Analysis.

[3]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[4]  Josep M. Pujol,et al.  Informing Optimal Environmental Influenza Interventions: How the Host, Agent, and Environment Alter Dominant Routes of Transmission , 2010, PLoS Comput. Biol..

[5]  E. Lau,et al.  Adiposity and influenza-associated respiratory mortality: a cohort study. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  A. Morice,et al.  Sex-related differences in cough reflex sensitivity in patients with chronic cough. , 2002, American journal of respiratory and critical care medicine.

[7]  Benjamin J. Cowling,et al.  Influenza Virus Aerosols in Human Exhaled Breath: Particle Size, Culturability, and Effect of Surgical Masks , 2010, Occupational and Environmental Medicine.

[8]  Timothy B. Stockwell,et al.  Quantifying influenza virus diversity and transmission in humans , 2016, Nature Genetics.

[9]  W. Schaffner,et al.  Obesity not associated with severity among hospitalized adults with seasonal influenza virus infection , 2015, Infection.

[10]  P. Koutrakis,et al.  Development and Performance Evaluation of an Exhaled-Breath Bioaerosol Collector for Influenza Virus , 2013, Aerosol science and technology : the journal of the American Association for Aerosol Research.

[11]  Benjamin J Cowling,et al.  Research findings from nonpharmaceutical intervention studies for pandemic influenza and current gaps in the research. , 2010, American journal of infection control.

[12]  Marshall Crumiller,et al.  Influenza A virus transmission bottlenecks are defined by infection route and recipient host. , 2014, Cell host & microbe.

[13]  Lidia Morawska,et al.  The mechanism of breath aerosol formation. , 2009, Journal of aerosol medicine and pulmonary drug delivery.

[14]  Raymond Tellier,et al.  Aerosol transmission of influenza A virus: a review of new studies , 2009, Journal of The Royal Society Interface.

[15]  A HarrisPaul,et al.  Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support , 2009 .

[16]  C. Donnelly,et al.  Contact transmission of influenza virus between ferrets imposes a looser bottleneck than respiratory droplet transmission allowing propagation of antiviral resistance , 2016, Scientific Reports.

[17]  C. Bridges,et al.  Transmission of influenza: implications for control in health care settings. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  Katia Koelle,et al.  Transmission Bottleneck Size Estimation from Pathogen Deep-Sequencing Data, with an Application to Human Influenza A Virus , 2017, Journal of Virology.

[19]  F. Hayden,et al.  Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. , 1998, The Journal of clinical investigation.

[20]  Tavis K. Anderson,et al.  Population dynamics of cocirculating swine influenza A viruses in the United States from 2009 to 2012 , 2013, Influenza and other respiratory viruses.

[21]  William G. Lindsley,et al.  Measurements of Airborne Influenza Virus in Aerosol Particles from Human Coughs , 2010, PloS one.

[22]  J. Twisk,et al.  Longitudinal tobit regression: a new approach to analyze outcome variables with floor or ceiling effects. , 2009, Journal of clinical epidemiology.

[23]  E Andres Houseman,et al.  Origin of exhaled breath particles from healthy and human rhinovirus-infected subjects. , 2011, Journal of aerosol medicine and pulmonary drug delivery.

[24]  Michael P. Atkinson,et al.  Quantifying the Routes of Transmission for Pandemic Influenza , 2008, Bulletin of mathematical biology.

[25]  T. Lash,et al.  Obesity as a risk factor for severe influenza-like illness , 2013, Influenza and other respiratory viruses.

[26]  D. Beezhold,et al.  Viable influenza A virus in airborne particles expelled during coughs versus exhalations , 2016, Influenza and other respiratory viruses.

[27]  E. Mirgorodskaya,et al.  Effect of airway opening on production of exhaled particles. , 2010, Journal of applied physiology.

[28]  J. Nam,et al.  Obesity-induced chronic inflammation is associated with the reduced efficacy of influenza vaccine , 2014, Human vaccines & immunotherapeutics.

[29]  K. Mengersen,et al.  Characterization of expiration air jets and droplet size distributions immediately at the mouth opening , 2008, Journal of Aerosol Science.

[30]  P V Nielsen,et al.  Short‐range airborne transmission of expiratory droplets between two people , 2017, Indoor air.

[31]  L. Rosella,et al.  Obesity and Respiratory Hospitalizations During Influenza Seasons in Ontario, Canada: A Cohort Study , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  Gerhard Scheuch,et al.  Inhaling to mitigate exhaled bioaerosols. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Michael Gardam,et al.  Questioning Aerosol Transmission of Influenza , 2007, Emerging infectious diseases.

[34]  Raymond Tellier,et al.  Review of Aerosol Transmission of Influenza A Virus , 2006, Emerging infectious diseases.

[35]  Gregory G King,et al.  HIGHLIGHTED TOPIC Pulmonary Physiology and Pathophysiology in Obesity Physiology of obesity and effects on lung function , 2009 .

[36]  Robert Schechter,et al.  Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. , 2009, JAMA.

[37]  Raymond Tellier,et al.  Transmission of influenza A in human beings. , 2007, The Lancet. Infectious diseases.

[38]  J. Nguyen-Van-Tam,et al.  Routes of influenza transmission , 2013, Influenza and other respiratory viruses.